Cancer cachexia syndrome in head and neck cancer patients: Part I. Diagnosis, impact on quality of life and survival, and treatment
- 6 February 2007
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 29 (4), 401-411
- https://doi.org/10.1002/hed.20447
Abstract
Background Cancer cachexia is a debilitating, wasting condition that affects many cancer patients, including those with head and neck cancer. The overall incidence of cancer cachexia is quite high for some types of cancer, and cachexia will be the main cause of death for more than 20% of all cancer patients. This syndrome uniquely challenges patients with head and neck cancer. This article outlines the diagnosis of cancer cachexia, reviews its impact on patient quality of life (QOL) and survival, and updates the reader on potential therapies that may suppress it. Methods A comprehensive literature search was performed using PubMed of the National Library of Medicine, which includes more than 15 million citations back to the 1950s. The Cochrane Library and Google search engine were used as well. Results This syndrome differs significantly from starvation, and thus accurate and timely diagnosis is essential. Nutritional therapy alone is insufficient. Current management strategies include corticosteroids and megesterol acetate, in conjunction with nutritional therapy. Future strategies may include nutraceuticals, omega‐3 fatty acids, inflammatory antagonists, and other targeted treatments. Conclusions Because cancer cachexia differs significantly from starvation, nutritional supplementation must be used in conjunction with other anti‐cachexia agents to reverse the chronic systemic inflammatory state and the effects of circulating tumor‐derived factors seen in cachexia. Careful identification of patients at risk and those suffering from this syndrome will lead to better outcomes and treatments. Ultimately, more research is needed to better treat this devastating condition. © 2007 Wiley Periodicals, Inc. Head Neck, 2007Keywords
This publication has 53 references indexed in Scilit:
- Quality of life as predictor of weight loss in patients with head and neck cancerHead & Neck, 2005
- Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy?a pilot studySupportive Care in Cancer, 2004
- A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patientsSupportive Care in Cancer, 2004
- Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon‐26 adenocarcinomaResearch in Nursing & Health, 2004
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- Increased Mortality Associated with Growth Hormone Treatment in Critically Ill AdultsNew England Journal of Medicine, 1999
- Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?European Journal Of Cancer, 1998
- Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide YPeptides, 1996
- Stellung des Megestrolacetates in der Behandlung der Kachexie bei Kopf-Hals-Tumoren*Laryngo-Rhino-Otologie, 1995
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsAmerican Journal Of Medicine, 1980